13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 104 holding rows worth $4,831,008,336.
- Accession
- 0000950159-23-000074
- Filer
- CIK 1009258
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 104 entries on the cover page, a total value of $4,831,008,336 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,831,008,337 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 19,991,024 | $595,332,695 | dollars as filed | |
| GLAUKOS CORP | 377322AB8 | BOND | 271,752,000 | $312,639,806 | dollars as filed | principal |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 241,873,000 | $190,842,634 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,512,714 | $180,678,560 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607AB6 | DBCV 1.500%11/1 | 88,657,000 | $165,397,613 | dollars as filed | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 7,626,914 | $146,589,287 | dollars as filed | |
| IONIS PHARMACEUTICALS INC | 462222AD2 | NOTE 4/0 | 127,800,000 | $118,341,522 | dollars as filed | principal |
| TABULA RASA HEALTHCARE INC | 873379AA9 | NOTE | 144,516,000 | $114,624,311 | dollars as filed | principal |
| BROOKDALE SR LIVING INC | 112463AC8 | NOTE 2.000%10/1 | 145,955,000 | $112,249,612 | dollars as filed | principal |
| VIATRIS INC COM | 92556V106 | Stock | 10,000,000 | $111,300,000 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 5,884,448 | $109,450,733 | dollars as filed | |
| NATERA INC | 632307AB0 | BOND | 84,913,000 | $108,055,189 | dollars as filed | principal |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 2,693,000 | $99,506,350 | dollars as filed | |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 102,700,000 | $95,820,127 | dollars as filed | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845PAC2 | NOTE 3.500% 2/1 | 98,354,000 | $95,235,195 | dollars as filed | principal |
| NUVASIVE INC | 670704AL9 | BOND | 96,966,000 | $95,183,765 | dollars as filed | principal |
| AMEDISYS INC | 023436108 | COM | 1,136,080 | $94,908,123 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 11,077,927 | $94,494,717 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753UAB2 | NOTE 3.500% 9/1 | 51,885,000 | $79,433,341 | dollars as filed | principal |
| OAK STR HEALTH INC | 67181AAB3 | BOND | 100,000,000 | $75,994,000 | dollars as filed | principal |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,396,640 | $73,812,424 | dollars as filed | |
| PACIRA BIOSCIENCES INC | 695127AF7 | NOTE 0.750% 8/0 | 81,600,000 | $73,553,424 | dollars as filed | principal |
| IVERIC BIO INC | 46583P102 | COM | 3,424,852 | $73,326,081 | dollars as filed | |
| ACCOLADE INC | 00437EAB8 | NOTE 0.500% 4/0 | 105,000,000 | $73,303,650 | dollars as filed | principal |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 16,941,357 | $69,967,804 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 15,861,090 | $57,892,979 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 70,204,000 | $56,746,595 | dollars as filed | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 57,791,000 | $56,418,464 | dollars as filed | principal |
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 89,036,000 | $55,784,615 | dollars as filed | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 565,000 | $46,335,650 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 2,694,101 | $45,072,310 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 1,366,329 | $44,214,406 | dollars as filed | |
| LIVONGO HEALTH INC | 539183AA1 | NOTE 0.875% 6/0 | 50,000,000 | $43,769,000 | dollars as filed | principal |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 48,050,000 | $43,668,321 | dollars as filed | principal |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 2,032,335 | $39,630,533 | dollars as filed | |
| ENHABIT INC | 29332G102 | COM | 2,996,000 | $39,427,360 | dollars as filed | |
| 1LIFE HEALTHCARE INC | 68269GAB3 | BOND | 40,599,000 | $39,151,240 | dollars as filed | principal |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 2,349,228 | $38,503,847 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 2,380,438 | $36,825,376 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,161,826 | $36,004,988 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,933,137 | $35,162,245 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 12,679,651 | $34,615,447 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,966,345 | $34,290,948 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 700,000 | $33,565,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,743,628 | $31,681,721 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 6,358,314 | $31,537,237 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366JAD3 | NOTE 1.500% 9/1 | 32,000,000 | $31,357,440 | dollars as filed | principal |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,383,000 | $29,573,030 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 3,581,000 | $29,435,820 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,851,287 | $29,026,102 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 2,480,199 | $27,034,169 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,033,000 | $26,868,330 | dollars as filed | |
| HEALTH CATALYST INC | 42225TAB3 | BOND | 30,000,000 | $26,015,100 | dollars as filed | principal |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 2,052,010 | $25,650,125 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 3,319,000 | $24,925,690 | dollars as filed | |
| ACCENDRA HEALTH INC | 690732102 | COM | 1,179,000 | $23,025,870 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,796,261 | $22,370,088 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 800,000 | $22,248,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 891,587 | $21,237,602 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 964,033 | $20,745,990 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,324,214 | $19,412,977 | dollars as filed | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 1,750,000 | $17,447,500 | dollars as filed | |
| XERIS PHARMACEUTICALS INC | 98422LAA5 | NOTE 5.000% 7/1 | 18,000,000 | $17,094,600 | dollars as filed | principal |
| PRIME MEDICINE INC | 74168J101 | COM | 885,314 | $16,449,134 | dollars as filed | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 1,600,000 | $15,992,000 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 175,000 | $13,863,500 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 664,146 | $13,269,637 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 6,450,871 | $12,966,251 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 1,046,791 | $12,927,869 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 292,000 | $11,274,120 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 5,854,860 | $11,241,331 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,430,000 | $10,067,200 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $9,739,422 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 272,135 | $6,406,058 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $5,544,086 | dollars as filed | |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 6,500,000 | $5,471,570 | dollars as filed | principal |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 777,525 | $4,960,610 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 464,252 | $4,294,331 | dollars as filed | |
| ACUTUS MED INC | 005111109 | COM | 2,651,667 | $3,049,417 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $3,018,830 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 869,565 | $2,678,260 | dollars as filed | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 10,049,244 | $2,650,991 | dollars as filed | |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 5,281,713 | $2,640,857 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 455,262 | $2,271,757 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279119 | *W EXP 09/30/202 | 1,000,000 | $1,940,000 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 3,161,707 | $1,172,993 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 60,009 | $802,320 | dollars as filed | |
| ONCORUS INC | 68236R103 | COM | 2,536,186 | $642,416 | dollars as filed | |
| SIENTRA INC | 82621J105 | COM | 2,679,950 | $543,762 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 672,000 | $350,650 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 836,626 | $250,820 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $190,667 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $137,625 | dollars as filed | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $83,333 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $80,567 | dollars as filed | |
| PEAK BIO INC | 70470P116 | *W EXP 10/26/202 | 362,500 | $73,406 | dollars as filed | |
| SOMALOGIC INC | 83444k113 | WT | 120,000 | $48,000 | dollars as filed | |
| SENIOR CONNECT ACQUISITN COR | 81723H116 | *W EXP 12/31/202 | 500,000 | $30,050 | dollars as filed | |
| MEDTECH ACQUISITION CORP | 58507N113 | *W EXP 12/22/202 | 333,333 | $25,000 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $24,083 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 333,333 | $18,533 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $9,183 | dollars as filed | |
| MEDTECH ACQUISITION CORP | 58507N204 | UNIT 12/18/2025 | 1 | $10 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 1 | $10 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-23-000074 | this filing | 2023-02-14 | acceptance time not in the bulk data set |